Biochemical exploration of β-lactamase inhibitors
The alarming rise of microbial resistance to antibiotics has severely limited the efficacy of current treatment options. The prevalence of β-lactamase enzymes is a significant contributor to the emergence of antibiotic resistance. There are four classes of β-lactamases: A, B, C, and D. Class B is th...
Main Authors: | Varshaa Arer, Debasish Kar |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2022.1060736/full |
Similar Items
-
Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species
by: Annelien Everaert, et al.
Published: (2016-11-01) -
Role of β-Lactamase Inhibitors as Potentiators in Antimicrobial Chemotherapy Targeting Gram-Negative Bacteria
by: Song Zhang, et al.
Published: (2024-03-01) -
Broad-Spectrum Inhibitors against Class A, B, and C Type β-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization
by: Nabeela Farhat, et al.
Published: (2022-10-01) -
Evaluation of Metallo-β-Lactamase Susceptibility Testing in a Physiologic Medium
by: Tomefa E. Asempa, et al.
Published: (2021-12-01) -
Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol—An All-Inclusive Guide for Clinicians
by: Luigi Principe, et al.
Published: (2022-04-01)